Dietary Supplement
medium chain triglyceride oil
medium chain triglyceride oil is a dietary supplement with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 75.0%.
Total Trials
6
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
33%(1 trials)
Terminated
1(17%)
Phase Distribution
Ph not_applicable
5
83%
Ph phase_3
1
17%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
5(83.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(2)
Completed(3)
Terminated(1)
Detailed Status
Completed3
Recruiting1
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
75.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (16.7%)
N/A5 (83.3%)
Trials by Status
recruiting117%
completed350%
not_yet_recruiting117%
terminated117%
Recent Activity
1 active trials
Showing 5 of 6
not_yet_recruitingnot_applicable
Recovery With Exogenous Ketones and Antipsychotics
NCT07122531
recruitingnot_applicable
Nutritional Management of Post COVID-19 Cognitive Symptoms
NCT05705648
terminatedphase_3
Dietary Supplements for COVID-19
NCT04780061
completednot_applicable
Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment
NCT01669200
completednot_applicable
Ketone Levels Achieved After Medium Chain Triglyceride (MCT) Oil
NCT04389983
Clinical Trials (6)
Showing 6 of 6 trials
NCT07122531Not Applicable
Recovery With Exogenous Ketones and Antipsychotics
NCT05705648Not Applicable
Nutritional Management of Post COVID-19 Cognitive Symptoms
NCT04780061Phase 3
Dietary Supplements for COVID-19
NCT01669200Not Applicable
Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment
NCT04389983Not Applicable
Ketone Levels Achieved After Medium Chain Triglyceride (MCT) Oil
NCT03980327Not Applicable
Probiotics in Short Bowel Syndrome
All 6 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 6